Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

80.92 -0.09 (-0.10%)
Streaming Delayed Price Updated: 10:06 AM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Where Will DexCom Be in 5 Years?
Recent developments might have scared away some investors, but patience could pay off. 
Via The Motley Fool
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
From The Law Offices of Frank R. Cruz
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
DXCM Deadline in 7 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Looking Into DexCom's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today
Via Benzinga
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
A discounted stock can present an opportunity when there's a quality business behind it. 
Via The Motley Fool
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Down More Than 50% From Its High, Is DexCom Stock a Buy?
Is DexCom's business in trouble, or could this be a great buying opportunity for investors? 
Via The Motley Fool
Labaton Keller Sucharow LLP Announces Expanded Securities Class Action Lawsuit Filed Against DexCom, Inc. and Certain Executives
From Labaton Keller Sucharow LLP
Via Business Wire
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
2 Beaten-Down Growth Stocks You Might Regret Not Buying
Their headwinds won't last forever. 
Via The Motley Fool
Is DexCom a Millionaire Maker?
The company's game-changing technology could improve the lives of hundreds of millions of patients. 
Via The Motley Fool
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
Down More Than 50%, Is DexCom Stock a Bargain Now?
Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.